(Q80151014)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061315%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Towards an oral influenza vaccine: comparison between intragastric and intracolonic delivery of influenza subunit vaccine in a murine model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061315%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061315%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Amorij JP

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061315%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Westra TA

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061315%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Hinrichs WL

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061315%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Huckriede A

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061315%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

9 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061315%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061315%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061315%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061315%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

67-76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061315%20AND%20SRC:MED&resulttype=core&format=json

Pandemic versus epidemic influenza mortality: a pattern of changing age distribution

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Poliomyelitis: very small risks and very large risks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Needle-free vaccine delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Immunization without needles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Antibody in tears, saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Human immune responses to influenza virus vaccines administered by systemic or mucosal routes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Immunization against influenza in humans using an oral enteric-coated killed virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

The virosome concept for influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Enteric immunization of mice against influenza with recombinant vaccinia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

7 January 2021

Antigen delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

New generation of mucosal adjuvants for the induction of protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Towards an oral influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Conjugation of cholera toxin or its B subunit to liposomes for targeted delivery of antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Biodegradable microparticles of influenza viral vaccine: comparison of the effects of routes of administration on the in vivo immune response in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Oral immunization with influenza virus in biodegradable microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Oral pulsatile drug delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Time-controlled oral delivery systems for colon targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

A novel dissolution method relevant to intestinal release behaviour and its application in the evaluation of modified release mesalazine products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Assay of proteins in the presence of interfering materials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Cytoplasmic high-level expression of a soluble, enzymatically active form of the Escherichia coli penicillin-binding protein 5 and purification by dye chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Bacteriophage lambda cloning system for the construction of directional cDNA libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Quantification of antigen specific CD8+ T cells using an ELISPOT assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Antigen sampling across epithelial barriers and induction of mucosal immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Mucosal immunity: implications for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

Influenza infection in ferrets: role of serum antibody in protection and recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

7 January 2021

A novel particulate influenza vaccine induces long-term and broad-based immunity in mice after oral immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

7 January 2021

Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

7 January 2021

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.045

7 January 2021

10.1016/J.VACCINE.2007.10.045

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061315%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference